Karen Marie Walker - 06 Jun 2024 Form 4 Insider Report for Kyverna Therapeutics, Inc. (KYTX)

Role: Chief Technology Officer
Signature: By: /s/ Karen Walker
Issuer symbol: KYTX
Transactions as of: 06 Jun 2024
Net transactions value: +$42,591
Form type: 4
Filing time: 10 Jun 2024, 18:56:07 UTC
Previous filing: 07 Feb 2024
Next filing: 15 Apr 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	KYTX	Common Stock	Options Exercise	$42,591	+9,636		$4.42^*	9,636	06 Jun 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	KYTX	Stock Option (Right to Buy)	Options Exercise	$0	-9,636	-10%	$0.000000	82,648	06 Jun 2024	Common Stock	9,636	$4.42	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	25% of the original number of shares subject to the option vested on September 13, 2022, and 1/48th of the original number of shares subject to the option vested or shall vest in monthly installments thereafter.